Neuland traces its name from father Nieuwland who was an inspirational scientist at the University of Notre Dame, USA. Reverend Julius Aloysius (Arthur) Nieuwland, CSC, Ph.D., (14 February 1878 – 11 June 1936) was a Belgian-born Holy Cross priest and Professor of Chemistry and Botany at the University of Notre Dame. He is known for his contributions to acetylene research and its use as the basis for one type of synthetic rubber, which eventually led to the invention of neoprene by DuPont.
Dr. D R Rao, the Chairman of Neuland, attended the University of Notre Dame to study organic chemistry and was inspired by the somewhat legendary figure whose discoveries helped fund the university’s chemistry department. There was a clear link between chemistry and business and Chairman Rao named the business after the famous Nieuwland, with the name changed to NEULAND as we see it today.
Since those days over 30 years ago, Neuland has become a major player in the manufacture of APIs in India. This combined with an increased focus on a variety of niche products is feeding into a pipeline that will give a more profitable mix. The company’s ethos has always recognised ‘humanity’ and looking after people as its main remit. Neuland has achieved massive change in the last few years and this will undoubtedly put it in a stronger position to grasp the opportunity offered by its international customer base.
Here is a brief summary of some of the highlights of Neuland.
1984 January 7, Neuland Laboratories was incorporated in Hyderabad.
1986 June 30, Neuland made its first sale of salbutamol sulphate/albuterol sulfate.
1994 Neuland went public with an IPO; raised capital for construction of second production facility.
1997 Received first US FDA approval.
1999 Both manufacturing facilities inspected by USFDA.
Received Certificate of Suitability for Ranitidine.
2003 US and EU markets contribute over 40% of Neuland’s sales.
2004 Established North American operations.
2006 Number of products with Certificate of Suitability reaches nine.
US office started operations from California.
2007 Established Japanese subsidiary in Tokyo.
Inspected by German Health Authority (Unit 2).
2008 Certified in ISMS. SAP enabled Business Processes.
Unit 1 successfully inspected by USFDA.
Unit 1 Certified for ISO 14001 and OHSAS 18001.
2009 Unit 1 & 2 receive approval from PMDA of Japan (Neuland is one of the first Indian API manufacturers
to receive such an approval)
2010 Unit 2, Pashamylaram facility is certified for ISO 14001:2004 and OHSAS 18001:2007 standard.
2011 The year of challenge. EHS improvement took a leap forward resulting in lower raw material consumption
and fewer solvents with the saving of water and energy.
OHSAS 18001 Management system redefined at two main sites.
2012 Transformation of the Neuland model to target consistent growth in sales and more profitable product mix.
2013 The Neuland Way defined with many HR initiatives.
Restructuring of Business under Neuland name started.
2014 Joint business agreement with API Corporation Japan.
CMO awards winner.
New office in New Jersey (USA) opened.
Launch of high-value, niche product strategy. Opportunity and reality started as a new strategic initiative.